4.7 Review

The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33

Related references

Note: Only part of the references are listed.
Article Environmental Sciences

Counteractive Effects of IL-33 and IL-37 on Inflammation in Osteoarthritis

Vikrant Rai et al.

Summary: This study investigated the expression of IL-33 and IL-37 in human OA cartilage and found that IL-33 increased the expression of inflammatory mediators and favored phenotypic conversion towards the M1 phenotype, while IL-37 and blocking IL-33 had opposite effects. The results suggest that blocking IL-33 and increasing IL-37 may synergistically attenuate inflammation and could be potential therapeutics for OA.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Review Cell Biology

High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases

Simona Taverna et al.

Summary: This review focuses on the diverse functions of HMGB1 in cellular processes and its role in different oxidative stress-related chronic diseases. HMGB1 acts as a mediator in acute and chronic inflammation and may have beneficial effects on oxidative stress-related diseases.

CELLS (2022)

Article Cell Biology

Inhibition of HMGB1 suppresses inflammation and catabolism in temporomandibular joint osteoarthritis via NF-κB signaling pathway

Yan Yan Li et al.

Summary: This study reveals the crucial role of HMGB1 in inflammation and catabolism of temporomandibular joint osteoarthritis (TMJOA), and the inhibitory effect of HMGB1 on TMJOA through suppressing the NF-kappa B signaling pathway. HMGB1 may serve as a potential target for the treatment of TMJOA.

EUROPEAN JOURNAL OF HISTOCHEMISTRY (2022)

Article Immunology

Alarmins in autoimmune diseases

Maria Giovanna Danieli et al.

Summary: Alarmins are endogenous proteins or peptides released during non-programmed cell death, which can cause sterile inflammation. Studies have shown that different alarmins may play a role in the pathogenesis of various autoimmune and immune-mediated diseases. The literature review focuses on systemic autoimmune diseases and cutaneous organ-specific autoimmune diseases, and discusses the future prospects and potential therapeutic implications of alarmins in autoimmune diseases.

AUTOIMMUNITY REVIEWS (2022)

Article Orthopedics

The alarmins high mobility group box protein 1 and S100A8/A9 display different inflammatory profiles after acute knee injury

C. Aulin et al.

Summary: The concentrations of HMGB1 and S100A8/A9 in synovial fluid were compared among patients with knee injuries, osteoarthritis (OA), and knee healthy subjects. The study explored the associations of these alarmin levels with different joint injuries, inflammatory biomarkers, and degradation of bone and cartilage. The results indicated that HMGB1 and S100A8/A9 increased immediately after knee trauma and were associated with distinct downstream responses.

OSTEOARTHRITIS AND CARTILAGE (2022)

Article Cell Biology

Inhibition of HMGB1 suppresses inflammation and catabolism in temporomandibular joint osteoarthritis via NF-kappa B signaling pathway

Yan Yan Li et al.

Summary: HMGB1 plays a role in promoting synovial inflammation and cartilage degradation in temporomandibular joint osteoarthritis (TMJOA), and its inhibition can alleviate TMJOA by reducing inflammation and catabolism of cartilage.

EUROPEAN JOURNAL OF HISTOCHEMISTRY (2022)

Article Orthopedics

High Mobility Group Box I Protein in Osteoarthritic Knee Tissue and Chondrogenic Progenitor Cells: An Ex Vivo and In Vitro Study

Gunar Wagner et al.

Summary: The study reveals the chemoattractant role of HMGBI in knee OA, which attracts CPCs and stimulates migration through mechanisms involving RAGE and TLR4, providing a new regenerative approach for OA therapy.

CARTILAGE (2021)

Article Orthopedics

Glycyrrhizin, an HMGB1 inhibitor, Suppresses Interleukin-1β-Induced Inflammatory Responses in Chondrocytes from Patients with Osteoarthritis

Shifeng Zhou et al.

Summary: The study found that HMGB1 levels were significantly increased in OA patients' cartilage tissue, and glycyrrhizin was shown to inhibit IL-1 beta-induced upregulation of HMGB1 and inflammatory mediators, improving chondrocyte viability. Glycyrrhizin may be a potential therapy for OA patients and further research is needed for clinical application.

CARTILAGE (2021)

Article Dentistry, Oral Surgery & Medicine

HMGB1 contributes to osteoarthritis of temporomandibular joint by inducing synovial angiogenesis

Yaping Feng et al.

Summary: The study revealed that HMGB1 effectively upregulated the production of VEGF and HIF-1 alpha in TMJOA synovial fibroblasts through Erk and JNK activation. Conditioned medium from HMGB1-treated TMJOA synovial fibroblasts significantly promoted tube formation and migration in HUVECs, which was attenuated by specific inhibitor for VEGF. Moreover, the HMGB1 inhibitor abolished neovascularization in the rats' TMJOA synovium induced by CFA injection, leading to reduced levels of inflammatory cytokines in the synovial fluid.

JOURNAL OF ORAL REHABILITATION (2021)

Review Medicine, General & Internal

Diagnosis and Treatment of Hip and Knee Osteoarthritis A Review

Jeffrey N. Katz et al.

Summary: Osteoarthritis is a prevalent joint disease that can impact various joints, with risk factors including age, gender, obesity, genetics, and major joint injury. Treatment typically involves exercise, weight management, education, and medication therapy. Advanced cases may require surgical intervention for pain relief and improved function.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, Research & Experimental

MiR-129-5p shuttled by human synovial mesenchymal stem cell-derived exosomes relieves IL-1β induced osteoarthritis via targeting HMGB1

Min Qiu et al.

Summary: The study found that miR-129-5p was decreased and HMGB1 was increased in OA patients and IL-1 beta-induced chondrocytes. HS-MSC-Exo rich in miR-129-5p significantly reduced inflammation and apoptosis of chondrocytes, while HS-MSC-Exo deficient in miR-129-5p increased inflammation and apoptosis. MiR-129-5p targets HMGB1 to inhibit IL-1 beta-mediated OA.

LIFE SCIENCES (2021)

Article Biochemistry & Molecular Biology

Redox modifications of cysteine residues regulate the cytokine activity of HMGB1

Huan Yang et al.

Summary: The study found that the redox state of HMGB1 can regulate its inflammatory activity by controlling the formation of disulfide bonds, providing a new theoretical basis for the inactivation of HMGB1 during inflammation.

MOLECULAR MEDICINE (2021)

Review Biochemistry & Molecular Biology

Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis

Vilim Molnar et al.

Summary: Osteoarthritis is a common cause of disability worldwide, affecting all joint tissues equally. The pathogenesis involves low-grade inflammation leading to an imbalance between anabolic and catabolic processes. The complex network of cytokines regulating these processes plays a central role in the development and progression of osteoarthritis, with concentrations of proinflammatory and anti-inflammatory cytokines varying based on disease stage and activity levels.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Orthopedics

Early stage blockade of the alarmin HMGB1 reduces cartilage destruction in experimental OA

C. Aulin et al.

OSTEOARTHRITIS AND CARTILAGE (2020)

Article Immunology

Blockade of IL-33 signalling attenuates osteoarthritis

Zengliang He et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)

Article Orthopedics

LncRNA MCM3AP-AS1 regulates miR-142-3p/HMGB1 to promote LPS-induced chondrocyte apoptosis

Yanjun Gao et al.

BMC MUSCULOSKELETAL DISORDERS (2019)

Review Pharmacology & Pharmacy

Extracellular HMGB1 as a therapeutic target in inflammatory diseases

Ulf Andersson et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2018)

Article Biochemistry & Molecular Biology

29-kDa FN-f inhibited autophagy through modulating localization of HMGB1 in human articular chondrocytes

Hyun Sook Hwang et al.

BMB REPORTS (2018)

Review Immunology

HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins

Damien Bertheloot et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2017)

Article Biochemistry & Molecular Biology

BRD4 has dual effects on the HMGB1 and NF-κB signalling pathways and is a potential therapeutic target for osteoarthritis

Jiang Yafei et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)

Article Dentistry, Oral Surgery & Medicine

The expression of high-mobility group box protein-1 in temporomandibular joint osteoarthritis with disc perforation

Yaping Feng et al.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)

Review Rheumatology

Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis

William H. Robinson et al.

NATURE REVIEWS RHEUMATOLOGY (2016)

Review Medicine, General & Internal

Knee osteoarthritis: a review of management options

S. M. Hussain et al.

SCOTTISH MEDICAL JOURNAL (2016)

Article Medical Laboratory Technology

Synovial Fluid HMGB-1 Levels are Associated with Osteoarthritis Severity

Xueru Ke et al.

CLINICAL LABORATORY (2015)

Article Immunology

MD-2 is required for disulfide HMGB1-dependent TLR4 signaling

Huan Yang et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Article Medicine, General & Internal

Osteoarthritis

S. Glyn-Jones et al.

LANCET (2015)

Editorial Material Medicine, General & Internal

The functions of HMGB1 depend on molecular localization and post-translational modifications Introduction

U. Andersson et al.

JOURNAL OF INTERNAL MEDICINE (2014)

Review Pharmacology & Pharmacy

An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies

Domenica Musumeci et al.

PHARMACOLOGY & THERAPEUTICS (2014)

Review Orthopedics

Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)

F. Berenbaum

OSTEOARTHRITIS AND CARTILAGE (2013)

Review Allergy

Role of Interleukin-33 in Innate-Type Immune Cells in Allergy

Susumu Nakae et al.

ALLERGOLOGY INTERNATIONAL (2013)

Review Rheumatology

Osteoarthritis: A disease of the joint as an organ

Richard F. Loeser et al.

ARTHRITIS AND RHEUMATISM (2012)

Article Immunology

Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release

Emilie Venereau et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2012)

Review Cell Biology

High-mobility group box 1 (HMGB1) as a master regulator of innate immunity

Alessandra Castiglioni et al.

CELL AND TISSUE RESEARCH (2011)

Article Medicine, General & Internal

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis

Yeon-Sik Hong et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2011)

Article Medicine, Research & Experimental

Correlation of synovial fluid HMGB-1 levels with radiographic severity of knee osteoarthritis

Zhan-Chun Li et al.

CLINICAL AND INVESTIGATIVE MEDICINE (2011)

Article Rheumatology

Interleukin-6 Is a Significant Predictor of Radiographic Knee Osteoarthritis The Chingford Study

Gregory Livshits et al.

ARTHRITIS AND RHEUMATISM (2009)

Article Cell Biology

The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation

Hulda Sigridur Hreggvidsdottir et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2009)

Review Medicine, Research & Experimental

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation

Louis J. Sparvero et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2009)

Article Immunology

HMGB1 develops enhanced binding to cytokines

Yonggang Sha et al.

JOURNAL OF IMMUNOLOGY (2008)

Article Medicine, Research & Experimental

Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils

Maho Suzukawa et al.

LABORATORY INVESTIGATION (2008)

Review Biochemistry & Molecular Biology

HMGB1: Endogenous danger signaling

John R. Klune et al.

MOLECULAR MEDICINE (2008)

Article Rheumatology

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States

Reva C. Lawrence et al.

ARTHRITIS AND RHEUMATISM (2008)

Article Biochemistry & Molecular Biology

Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells

David Moulin et al.

CYTOKINE (2007)

Article Biochemistry & Molecular Biology

Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification

Noboru Taniguchi et al.

MOLECULAR AND CELLULAR BIOLOGY (2007)

Article Cardiac & Cardiovascular Systems

High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells

Emmanouil Chavakis et al.

CIRCULATION RESEARCH (2007)

Article Multidisciplinary Sciences

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

Virginie Carriere et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Review Biochemistry & Molecular Biology

T1/ST2 - an IL-1 receptor-like modulator of immune responses

V Trajkovic et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2004)

Article Hematology

Regulation of monocyte migration by amphoterin (HMGB1)

A Rouhiainen et al.

BLOOD (2004)

Article Multidisciplinary Sciences

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

P Scaffidi et al.

NATURE (2002)

Article Biochemistry & Molecular Biology

Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V

K Tago et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)